Search

everythinglearnresearchcommunity

for

Search:↓

Special cells can help regrow hair in alopecia areata.

A new genetic mutation in the CDH3 gene causes hair loss and eye problems in young people.

γδ T cells adapt uniquely to different tissues in mice.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Rubbing vitamin D3 on skin can help prevent hair loss from chemotherapy and slow breast tumor growth in mice.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

A3 antibody helps identify key cells in rat hair follicle development.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

TR3 is mainly found in hair follicle stem cells and may be involved in hair loss.

Activating TLR3 helps improve skin and hair follicle regeneration after wounds.

Targeting specific T cells may help treat alopecia areata.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

CDH3-related disease causes worsening eye and hair issues.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Stat3 influences keratinocyte stem cell behavior, affecting differentiation and migration.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Dermal IgA deposition without symptoms is rare in Dermatitis herpetiformis risk groups.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Different γδ T cell types have unique roles in causing alopecia areata.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.